Logo

American Heart Association

  71
  0


Final ID: Thu052

Development of a Comprehensive Biobank of Human iPSC Lines for Open-Access Distribution to Academic Researchers

Abstract Body: Background
Human induced pluripotent stem cells (iPSCs) have revolutionized biomedical, translational and toxicology research in many fields such as cardiovascular disease, development, aging, regeneration, cancer, personalized medicine, and many rare diseases. The need for obtaining iPSC lines with the associated donors’ clinical data and from patients of diverse genetic backgrounds has been greater than ever. Greenstone Biosciences Inc. (GSB) has built a curated biorepository to address this demand as an asset for the scientific community utilizing iPSCs.

Methods
The GSB biobank curates clinical data, isolates peripheral blood mononuclear cells (PBMCs), reprograms and banks patient-specific iPSC lines, and performs quality assurance. Reprogramming of PBMCs to iPSCs is carried out using non-integrating Sendai virus encoding for Oct4, Sox2, Klf4, and c-Myc. We then rigorously validate all iPSCs for pluripotency using immunofluorescence of stemness markers, qRT-PCR, G-banding and SNP-based virtual karyotyping along with quality control methods recommended by the International Society for Stem Cell Research (ISSCR).

Results
We have a growing repository of over 1,000 iPSC lines with various disease backgrounds across demographics. We have an equal distribution of sex with 54% male and 46% female patients. We have representation of various populations including White non-Hispanic (56.9%), Hispanic or Latino (14.1%), East Asian (8%), African American (6.6%), and South Asian (5.7%). While 10% of the repository are cells from healthy donors, the bulk of our repository cell lines represent inherited cardiovascular diseases with known genetic mutations including hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM), long QT syndrome (LQTS) and many other rare conditions such as Brugada syndrome (BrS) and Duchenne’s muscular dystrophy (DMD). We have also established a simple material transfer agreement (MTA) making it extremely accessible for academic and other non-profit institutions.

Conclusions
We introduce the Greenstone Biosciences iPSC Biobank, a biorepository containing >1,000 human iPSC lines with de-identified patient clinical information and genetic backgrounds. This invaluable resource will help support iPSC research among academic investigators and institutions in several clinical, therapeutic, regulatory and biomedical research fields.
  • Yan, Christopher  ( Greenstone Biosciences , Palo Alto , California , United States )
  • Pang, Paul  ( Greenstone Biosciences , Palo Alto , California , United States )
  • Herron, Todd  ( Greenstone Biosciences , Palo Alto , California , United States )
  • Lai, Celine  ( Greenstone Biosciences , Palo Alto , California , United States )
  • Yu, Rebecca  ( Greenstone Biosciences , San Jose , California , United States )
  • Cook, Zach  ( Greenstone Biosciences , Palo Alto , California , United States )
  • Shenoy, Sushma Prabhakar  ( Greenstone Biosciences , Palo Alto , California , United States )
  • Dolivo, David  ( Greenstone Biosciences , Palo Alto , California , United States )
  • Walther, Parker  ( Greenstone Biosciences , Palo Alto , California , United States )
  • Zhuge, Yan  ( STANFORD UNIV SCH OF MEDICINE , Stanford , California , United States )
  • Wu, Joseph  ( STANFORD UNIV SCH OF MEDICINE , Stanford , California , United States )
  • Author Disclosures:
    Christopher Yan: DO have relevant financial relationships ; Employee:Greenstone Biosciences:Active (exists now) | Paul Pang: No Answer | Todd Herron: DO have relevant financial relationships ; Employee:Greenstone Biosciences:Active (exists now) ; Advisor:Kataoka Corporation:Active (exists now) ; Advisor:StemBioSys, Inc.:Active (exists now) | Celine Lai: No Answer | Rebecca Yu: DO NOT have relevant financial relationships | Zach Cook: DO NOT have relevant financial relationships | Sushma Prabhakar Shenoy: DO NOT have relevant financial relationships | David Dolivo: DO NOT have relevant financial relationships | Parker Walther: No Answer | Yan Zhuge: DO NOT have relevant financial relationships | Joseph Wu: DO NOT have relevant financial relationships
Meeting Info:

Basic Cardiovascular Sciences 2025

2025

Baltimore, Maryland

Session Info:

Poster Session and Reception 2

Thursday, 07/24/2025 , 04:30PM - 07:00PM

Poster Session and Reception

More abstracts on this topic:
An Overlap Between Takotsubo Cardiomyopathy and Hypertrophic Obstructive Cardiomyopathy Causing Dynamic Left Ventricular Outflow Tract Obstruction: A Unique Case Report

Sharif Muhammad Hammad, Latifi Ahmad Nawid, Naeem Nauman, Baibhav Bipul, Khaleeque Madeeha, Sanjeevi Aditya

2-Deoxyuridine Associates with Recurrent Coronary Events

Pistritu Dan, Castano David, Liehn Elisa, Koh Cho Yeow, Gerszten Robert, Singaraja Roshni, Chan Mark, Shah Svati

More abstracts from these authors:
ADMET-AI enables interpretable predictions of drug-induced cardiotoxicity

Swanson Kyle, Wu Joseph, Mukherjee Souhrid, Walther Parker, Lai Celine, Yan Christopher, Shivnaraine Rabindra, Leitz Jeremy, Pang Paul, Zou James

Stem Cells, Genomics, and AI for Drug Discovery

Wu Joseph

You have to be authorized to contact abstract author. Please, Login
Not Available